These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 15753622

  • 21. Rho regulates the hepatocyte growth factor/scatter factor-stimulated cell motility of human oral squamous cell carcinoma cells.
    Kitajo H, Shibata T, Nagayasu H, Kawano T, Hamada J, Yamashita T, Arisue M.
    Oncol Rep; 2003; 10(5):1351-6. PubMed ID: 12883706
    [Abstract] [Full Text] [Related]

  • 22. Caspase cleavage of the MET receptor generates an HGF interfering fragment.
    Deheuninck J, Foveau B, Goormachtigh G, Leroy C, Ji Z, Tulasne D, Fafeur V.
    Biochem Biophys Res Commun; 2008 Mar 14; 367(3):573-7. PubMed ID: 18187039
    [Abstract] [Full Text] [Related]

  • 23. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M.
    Cancer Res; 2000 Nov 01; 60(21):6148-59. PubMed ID: 11085539
    [Abstract] [Full Text] [Related]

  • 24. Hepatocyte growth factor/scatter factor is not a potent regulator of anabolic and catabolic gene expression in adult human articular chondrocytes.
    Bau B, McKenna LA, Soeder S, Fan Z, Pecht A, Aigner T.
    Biochem Biophys Res Commun; 2004 Apr 16; 316(4):984-90. PubMed ID: 15044081
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M, Li Z, Marreli M, Nguyen BT, Park M, Wong K.
    Cell Growth Differ; 1997 Apr 16; 8(4):451-62. PubMed ID: 9101091
    [Abstract] [Full Text] [Related]

  • 26. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
    Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R.
    Cancer Res; 2006 Feb 01; 66(3):1721-9. PubMed ID: 16452232
    [Abstract] [Full Text] [Related]

  • 27. Hepatocyte growth factor induces apoptosis through the extrinsic pathway in hepatoma cells: favouring role of hypoxia-inducible factor-1 deficiency.
    Matteucci E, Modora S, Simone M, Desiderio MA.
    Oncogene; 2003 Jun 26; 22(26):4062-73. PubMed ID: 12821940
    [Abstract] [Full Text] [Related]

  • 28. Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps.
    Rho HS, Lee SH, Lee HM, Lee SH, Jung HH, Choi J, Park MK, Kang SM.
    Arch Otolaryngol Head Neck Surg; 2006 Sep 26; 132(9):985-9. PubMed ID: 16982975
    [Abstract] [Full Text] [Related]

  • 29. Expression of beta-catenin in external auditory canal cholesteatoma (EACC).
    Naim R, Riedel F, Bran G, Hörmann K.
    Biofactors; 2003 Sep 26; 19(3-4):189-95. PubMed ID: 14757970
    [Abstract] [Full Text] [Related]

  • 30. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas.
    Harvey P, Warn A, Newman P, Perry LJ, Ball RY, Warn RM.
    J Pathol; 1996 Dec 26; 180(4):389-94. PubMed ID: 9014859
    [Abstract] [Full Text] [Related]

  • 31. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
    Jeffers M, Rong S, Anver M, Vande Woude GF.
    Oncogene; 1996 Aug 15; 13(4):853-6. PubMed ID: 8761307
    [Abstract] [Full Text] [Related]

  • 32. Effect of vascular endothelial growth factor on fibroblasts from external auditory canal cholesteatoma.
    Naim R, Chang RC, Sadick H, Bayerl C, Bran G, Hormann K.
    Arch Med Res; 2005 Aug 15; 36(5):518-23. PubMed ID: 16099332
    [Abstract] [Full Text] [Related]

  • 33. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS, Wang JT, Chang YF, Liu BY, Wang YP, Sun A, Chiang CP.
    J Oral Pathol Med; 2004 Apr 15; 33(4):209-17. PubMed ID: 15061708
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP, Hose CD, Koochekpour S, Jeffers M, Oskarsson M, Sausville E, Monks A, Vande Woude GF.
    Cancer Res; 2000 Jan 15; 60(2):342-9. PubMed ID: 10667586
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Levels of hepatocyte growth factor/scatter factor (HGF/SF) in seminal plasma of patients with andrological diseases.
    Depuydt CE, De Potter CR, Zalata A, Baekelandt E, Bosmans E, Comhaire FH.
    J Androl; 1998 Jan 15; 19(2):175-82. PubMed ID: 9570740
    [Abstract] [Full Text] [Related]

  • 39. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium.
    Nusrat A, Parkos CA, Bacarra AE, Godowski PJ, Delp-Archer C, Rosen EM, Madara JL.
    J Clin Invest; 1994 May 15; 93(5):2056-65. PubMed ID: 8182137
    [Abstract] [Full Text] [Related]

  • 40. Expression of hepatocyte growth factor/scatter factor and its receptor, MET, suggests roles in human embryonic organogenesis.
    Kolatsi-Joannou M, Moore R, Winyard PJ, Woolf AS.
    Pediatr Res; 1997 May 15; 41(5):657-65. PubMed ID: 9128288
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.